PL2193789T3 - Zastosowanie 5-metylo-1,3-benzenodiolu lub jego pochodnych w przygotowaniu leku i funkcjonalnej żywności do leczenia lub zapobiegania depresji - Google Patents

Zastosowanie 5-metylo-1,3-benzenodiolu lub jego pochodnych w przygotowaniu leku i funkcjonalnej żywności do leczenia lub zapobiegania depresji

Info

Publication number
PL2193789T3
PL2193789T3 PL08783745T PL08783745T PL2193789T3 PL 2193789 T3 PL2193789 T3 PL 2193789T3 PL 08783745 T PL08783745 T PL 08783745T PL 08783745 T PL08783745 T PL 08783745T PL 2193789 T3 PL2193789 T3 PL 2193789T3
Authority
PL
Poland
Prior art keywords
dihydroxytoluene
medicine
derivatives
treating
preparation
Prior art date
Application number
PL08783745T
Other languages
English (en)
Inventor
Jijun Chen
Lin Xu
Jun Zhou
Jun Lu
Rongrong Mao
Meng Tian
Qixin Zhou
Xuemei Zhang
Yong Shen
Zhiyong Jiang
Aixue Zuo
Original Assignee
Kunming Inst Botany Cas
Kunming Inst Zoology Cas
Kunming Jingbiao Biosciences R&D Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kunming Inst Botany Cas, Kunming Inst Zoology Cas, Kunming Jingbiao Biosciences R&D Co Ltd filed Critical Kunming Inst Botany Cas
Publication of PL2193789T3 publication Critical patent/PL2193789T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL08783745T 2007-08-03 2008-07-25 Zastosowanie 5-metylo-1,3-benzenodiolu lub jego pochodnych w przygotowaniu leku i funkcjonalnej żywności do leczenia lub zapobiegania depresji PL2193789T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200710066088A CN100586429C (zh) 2007-08-03 2007-08-03 一种抗抑郁药物
EP08783745.6A EP2193789B8 (en) 2007-08-03 2008-07-25 The application of 5-methyl-1,3-benzenediol or derivatives thereof in the preparation of medicines and functional foods for treatment or prevention of depression
PCT/CN2008/071752 WO2009018747A1 (fr) 2007-08-03 2008-07-25 Utilisation du 3,5-dihydrotoluène ou de ses dérivés dans la préparation de médicaments ou de nourriture fonctionnelle destinés au traitement ou à la prévention de la dépression

Publications (1)

Publication Number Publication Date
PL2193789T3 true PL2193789T3 (pl) 2013-07-31

Family

ID=39020996

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08783745T PL2193789T3 (pl) 2007-08-03 2008-07-25 Zastosowanie 5-metylo-1,3-benzenodiolu lub jego pochodnych w przygotowaniu leku i funkcjonalnej żywności do leczenia lub zapobiegania depresji

Country Status (18)

Country Link
US (1) US8859508B2 (pl)
EP (1) EP2193789B8 (pl)
JP (1) JP4714304B2 (pl)
KR (1) KR101213570B1 (pl)
CN (2) CN100586429C (pl)
AU (1) AU2008286096B2 (pl)
BR (1) BRPI0813085A2 (pl)
CA (1) CA2694881C (pl)
DK (1) DK2193789T3 (pl)
ES (1) ES2404819T3 (pl)
IL (1) IL203102A (pl)
MX (1) MX2010001221A (pl)
NZ (1) NZ583449A (pl)
PL (1) PL2193789T3 (pl)
PT (1) PT2193789E (pl)
RU (1) RU2447887C2 (pl)
WO (1) WO2009018747A1 (pl)
ZA (1) ZA201001117B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100586429C (zh) 2007-08-03 2010-02-03 中国科学院昆明植物研究所 一种抗抑郁药物
CN103058830B (zh) * 2012-12-13 2015-09-30 大兴安岭林格贝寒带生物科技股份有限公司 一种石梅衣中提取地衣酚的生产技术
CN111153947B (zh) * 2019-08-21 2021-03-09 云南巅青生物科技有限公司 芳环化合物
CN111233951A (zh) * 2020-03-20 2020-06-05 中国科学院昆明植物研究所 苔黑酚葡萄糖苷的制备方法
CN116359519B (zh) * 2023-05-29 2023-09-15 中国人民解放军军事科学院军事医学研究院 CLDN5蛋白、Cldn5基因及其修饰在抑郁障碍诊断和/或治疗中的应用
CN119462467B (zh) * 2024-11-12 2025-09-26 安徽医科大学 一种酚类化合物及其制备方法和在制备治疗围绝经期抑郁症药物上的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0474988A1 (fr) 1990-07-20 1992-03-18 Firmenich Sa Composition aromatisante et aliments la contenant
JP3519747B2 (ja) * 1992-09-25 2004-04-19 高砂香料工業株式会社 鎮静効果を与える香料改質剤
CN1055238C (zh) * 1997-04-18 2000-08-09 宋杨 安神解忧丸及其制备方法
US6495512B1 (en) * 2000-06-23 2002-12-17 International Flavors & Fragrances Inc. Salicylaldehyde-containing composition having antimicrobial and fragrancing properties and process for using same
RU2215728C2 (ru) * 2002-01-08 2003-11-10 Открытое акционерное общество "Ангарский завод полимеров" 3,5-дигидрокситолуол(орцинол) для ингибирования термополимеризации при переработке жидких продуктов пиролиза
JP2004135522A (ja) * 2002-10-16 2004-05-13 Kiyomitsu Kawasaki 魚節フレーバー組成物および該フレーバー組成物を含有する食品類
RU2238318C1 (ru) * 2003-06-20 2004-10-20 Открытое акционерное общество "Восток" Способ стабилизации и активации гидролитических ферментов
CN100506769C (zh) * 2004-04-09 2009-07-01 中国科学院上海药物研究所 蛋白酪氨酸磷酸酯酶1b抑制剂1，3-二羟基-5-烷基苯类化合物的用途
WO2007109783A2 (en) * 2006-03-23 2007-09-27 Janssen Pharmaceutica, N.V. Substituted pyrimidine kinase inhibitors
CN100586429C (zh) * 2007-08-03 2010-02-03 中国科学院昆明植物研究所 一种抗抑郁药物

Also Published As

Publication number Publication date
ES2404819T3 (es) 2013-05-29
DK2193789T3 (da) 2013-05-21
JP2010535160A (ja) 2010-11-18
CN101742992B (zh) 2013-01-23
NZ583449A (en) 2012-04-27
US8859508B2 (en) 2014-10-14
IL203102A (en) 2013-10-31
JP4714304B2 (ja) 2011-06-29
RU2010106275A (ru) 2011-09-10
CN100586429C (zh) 2010-02-03
AU2008286096B2 (en) 2011-02-03
EP2193789A4 (en) 2011-10-05
WO2009018747A1 (fr) 2009-02-12
RU2447887C2 (ru) 2012-04-20
EP2193789B8 (en) 2013-06-26
PT2193789E (pt) 2013-05-17
HK1140132A1 (en) 2010-10-08
EP2193789B1 (en) 2013-02-20
CA2694881C (en) 2013-02-19
CA2694881A1 (en) 2009-02-12
EP2193789A1 (en) 2010-06-09
AU2008286096A1 (en) 2009-02-12
CN101112367A (zh) 2008-01-30
MX2010001221A (es) 2010-05-17
CN101742992A (zh) 2010-06-16
BRPI0813085A2 (pt) 2019-09-24
KR101213570B1 (ko) 2012-12-18
US20100190730A1 (en) 2010-07-29
KR20100030679A (ko) 2010-03-18
ZA201001117B (en) 2011-11-30

Similar Documents

Publication Publication Date Title
IL202379A (en) Benzoxaborols, their pharmaceutical preparations and their use in the preparation of bacteria to inhibit the growth of germs
IL216599A (en) 4,1-Bi-Conjugated Phthalazine History, Pharmaceuticals Containing Them and Their Use in Cancer Treatment
MX2008000210A (en) Food articles with delivery devices and methods for the preparation thereof
EP1940361A4 (en) PHARMACEUTICAL DOSAGE FORMS HAVING CONTROLLED AND / OR IMMEDIATE RELEASE PROPERTIES
IL194835A (en) History of cyclohexylpyrazole-lactam, an intermediate substance for their use in the preparation of drugs
IL194699A (en) Tetrahydropridridines, preparations containing them and uses in the preparation of drugs
IL219876A (en) Antibodies against human 1h-7b or its fragment, preparations containing them and their use in the preparation of drugs
IL178390A0 (en) Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
ZA200800206B (en) "One-way valve for medical infusion lines and the like"
IL206952A (en) History of Aminodia Hydrothiazine, medicinal preparations containing them, and their use in the preparation of medicines
IL206080A0 (en) Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
IL206296A (en) History of aminopyrazole, and their medicinal products and their use in the preparation of drugs for the prevention and treatment of diseases
IL186127A (en) Subcutaneous preparations for the treatment of depression and methods for their preparation
IL201730A (en) History 1h - Benzaimidazole – 2 – Il – Profile – Methyl – Amino – Ethyl – 5 – Aryl – Bicyclo [2.2.2] Oct – 5 – Ann – 2 – All, Pharmaceutical preparations containing them and their use in the preparation of drugs
MY148723A (en) Use of pinolenic acid for the treatment of obesity
EP2208732A4 (en) DEHYDROXYLATED VANCOMYCIN, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF
IL215483A (en) 6,4,2-Triple fluoro-n- [6- (1-methyl-piperidine-4-carbonyl) -pyrimidine-2-yl] -benzamide and its use in the preparation of a drug to treat or prevent migraines
WO2009068708A8 (es) Composición farmacéutica de liberación sostenida de somatostatina o un análogo suyo
IL215840A (en) Arylsulfonamide compounds are converted into two positions 2 and 5, their pharmaceutical composition containing them and their use in the treatment of ccr3-related diseases
IL194880A (en) Aminazole amine derivatives, their use in the treatment of diseases and pharmaceuticals containing them
PL2193789T3 (pl) Zastosowanie 5-metylo-1,3-benzenodiolu lub jego pochodnych w przygotowaniu leku i funkcjonalnej żywności do leczenia lub zapobiegania depresji
ZA200903865B (en) Pyrrole derivatives, preparation and use of the same in therapy
IL201426A0 (en) Drug combination and its use in the treatment of muscle loss
EP2005964A4 (en) MEDICAMENT FOR TREATING HYPERPHOSPHATEEMIA AND PREPARATION METHOD THEREOF
IL204957A (en) Derivatives of 3 - (aminoalkoxyimino) - androstane and androsten